Medical journals and the shaping of medical knowledge

Lancet

Volumn 352, Issue 9145, 1998, Pages 2001-2006

  Vandenbroucke, Jan P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEOPATHY; INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICINE; PRIORITY JOURNAL; REVIEW; ANIMAL; CLINICAL TRIAL; CONFLICT OF INTEREST; CONTROLLED CLINICAL TRIAL; HISTORY; HUMAN; KNOWLEDGE; META ANALYSIS; PEER REVIEW; PUBLICATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; CONFLICT OF INTEREST; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; KNOWLEDGE; META-ANALYSIS; PEER REVIEW, RESEARCH; PERIODICALS; PUBLISHING; RANDOMIZED CONTROLLED TRIALS;

EID: 0032570181     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)10208-8     Document Type: Note

References (23)

1. 1 Morabia A. PCA Louis and the birth of clinical epidemiology. J Clin Epidemiol 1996; 49: 1327-33.
2. 2 Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998; 279: 1566-70.
3. 3 World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582-88.
4. 4 Jick H, Jich SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-93.
5. 5 Boelmenkamp KWM, Rasendaal FR, Helmershorst FM, Büller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593-96.
6. 6 Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, Macrae KD on behalf of Transnational Research Group on Oral Contraceptives and the Health of Young Women. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study, BMJ 1996; 312: 82-88.
7. 7 Farmer RDT, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton TR. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997; 349: 83-88.
8. 8 Lindegaard Ø, Edström B, Kreiner S. Oral contraceptives and venous thromboembolism: a case-controls study. Contraception 1998; 57: 291-301.
9. 9 Light RJ, Pillemer DB, Summing up - the science of reviewing research. Cambridge, MA: Harvard University Press, 1984.
10. 10 Linde K, Clausius N, Ramirez G, et al. Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997; 350: 834-43.
11. 11 Altman DG, Doré CJ. Randomisation and baseline comparisons in clinical trials. Lancet. 1990; 335: 149-53.
12. 12 Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med 1986; 1: 155-58.
13. 13 Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low-moecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152-56.
14. 14 Thomas DP. Does low molecular weight heparin cause less bleeding? Thromb Haemost 1997; 78: 1422-25.
15. 15 Denissenko MF, Pao A, Tang KS, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer hotspots in p53. Science 1996; 274: 430-32.
16. 16 Rosing J, Tans G, Nicolaes GAF, et al. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second-and third generation oral contraceptives. Br J Haematol 1997; 97: 233-38.
17. 17 Cullen W. Method of study. In: Passmore R, ed. Proc R Coll Phys Ed 1987; 18: 204-09.
18. 18 Fox T. Crisis in communication: the functions and future of medical journals. London: Athlone Press, 1965.
19. 19 Ben-Shloma Y, Davey Smith G. "Place of publication" bias? BMJ 1994; 309: 274.
20. 20 Smith R. Beyond conflict of interest. BMJ 1998; 317; 291-92.
21. 21 Davidoff F. New disease, old story. Ann Intern Med 1998; 129: 327-28.
22. 22 Chalmers I, Dickersin K, Chalmers TC. Getting to grips with Archie Cochrane's agenda. BMJ 1992; 305: 786-88.
23. 23 Anonymous. Lancet 1823; i: 1-2.